U.S. STEM CELL, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-09-13: Form 8-K; Period of report 2017-08-31; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2017-03-08: Form 8-K; Period of report 2017-03-03; Description 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; Details 2.01.
- 2017-03-06: Form 8-K; Period of report 2017-03-01; Description 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2017-09-13 | 8-K | 2017-08-31 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | usstemcell8k091117.htm |
| 2017-03-08 | 8-K | 2017-03-03 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On March 3, 2017, the Company entered into an Asset Sale and Lease Agreement with GACP (General American Capital Partners) Stem Cell Bank LLC, a Florida limited liability company (“GACP) to sell to GACP fully depreciated equipment (the “Equipment Assets”) related to the segment of the Company business involving collecting, growing and banking cell cultures (the “Human Banking Business”) for an aggregate of $500,000. | usstemcell8k030817.htm |
| 2017-03-06 | 8-K | 2017-03-01 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 3.02 Pursuant to the Settlement Agreement (see Item 1.01), the Company has issued twenty million (20,000,000) shares of unrestricted common stock to NorthStar in return for the full conversion of all of NorthStar’s shares of Series A Preferred Stock. 5.02 Pursuant to the Settlement Agreement (see Item 1.01), on March 5, 2017, Greg Knutson was appointed to serve as a member of our Board of Directors to serve until the next annual meeting, his earlier resignation or physical/mental incapacity or death. | usstemcell8k030617.htm |